Peer review reports
From: LncRNA MEG3 promotes cisplatin sensitivity of cervical cancer cells by regulating the miR-21/PTEN axis
Original Submission |
15 Mar 2022 |
Submitted |
Original manuscript
|
Resubmission - Version 2 |
|
Submitted |
Manuscript version 2
|
Resubmission - Version 3 |
|
Submitted |
Manuscript version 3
|
Resubmission - Version 4 |
|
Submitted |
Manuscript version 4
|
27 Jun 2022 |
Reviewed |
Reviewer Report
|
14 Jul 2022 |
Reviewed |
Reviewer Report
|
12 Aug 2022 |
Author responded |
Author comments - Bin Wei
|
Resubmission - Version 5 |
12 Aug 2022 |
Submitted |
Manuscript version 5
|
28 Aug 2022 |
Author responded |
Author comments - Bin Wei
|
Resubmission - Version 6 |
28 Aug 2022 |
Submitted |
Manuscript version 6
|
10 Sep 2022 |
Author responded |
Author comments - Bin Wei
|
Resubmission - Version 7 |
10 Sep 2022 |
Submitted |
Manuscript version 7
|
27 Sep 2022 |
Reviewed |
Reviewer Report
|
28 Sep 2022 |
Reviewed |
Reviewer Report
|
Resubmission - Version 8 |
|
Submitted |
Manuscript version 8
|
Publishing |
10 Oct 2022 |
Editorially accepted |
|
7 Nov 2022 |
Article published |
10.1186/s12885-022-10188-0
|
Learn about peer review